BC
TCRT icon

Boxer Capital’s Alaunos Therapeutics TCRT Stock Holding History

Boxer Capital’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,333
Closed -$145K – 68
2023
Q3 		$145K Sell
7,333
-2,667
-27% -$115K 0.01% 71
2023
Q2 		$765K Hold
10,000
– – 0.04% 74
2023
Q1 		$945K Hold
10,000
– – 0.05% 70
2022
Q4 		$974K Hold
10,000
– – 0.05% 65
2022
Q3 		$2.58M Buy
+10,000
New +$2.9M 0.15% 63

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Boxer Capital's TCRT Position: Q4 2023 in Review

Boxer Capital sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 7,333 shares — an estimated $145K sold.

Boxer Capital first reported a position in TCRT in Q3 2022 and held it in 5 quarters. The position peaked at $2.58M in Q3 2022. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • Boxer Capital reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Boxer Capital sold 7,333 Alaunos Therapeutics shares in Q4 2023, an estimated $145K.
  • Boxer Capital first reported a position in Alaunos Therapeutics in Q3 2022 and held it in 5 quarters.
  • Boxer Capital's Alaunos Therapeutics position peaked at $2.58M in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on Boxer Capital's 13F filing for Q4 2023, filed 14 Feb 2024.